- UroToday Home
- Recent Abstracts
- Urologic Oncology
Investigative Urology
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression - Abstract
October 26, 2011
Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age - Abstract
October 26, 2011
Macrophage-dependent cleavage of the laminin receptor {alpha}6{beta}1 in prostate cancer - Abstract
October 26, 2011
Molecular alterations during progression of prostate cancer to androgen independence - Abstract
October 26, 2011
SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer - Abstract
October 26, 2011
Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosomahaematobium infection - Abstract
October 26, 2011
Sex-reversed acampomelic campomelic dysplasia with a homozygous deletion mutation in SOX9 gene - Abstract
October 25, 2011
CD44 is a biomarker associated with human prostate cancer radiation sensitivity - Abstract
October 25, 2011
Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations - Abstract
October 25, 2011
Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer - Abstract
October 24, 2011
Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo - Abstract
October 24, 2011
Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth - Abstract
October 21, 2011
Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner - Abstract
October 21, 2011